Advertisement

Lung

, Volume 197, Issue 3, pp 303–313 | Cite as

The Economic Effect of Early Management in Patients with Early Chronic Obstructive Pulmonary Disease: Results from a Population-Based Nationwide Survey

  • Young Seok Lee
  • Kyung Hoon Min
  • Chin Kook Rhee
  • Yong Hyun Kim
  • Seong Yong Lim
  • Soo-Jung Um
  • Chang-Hoon Lee
  • Ki-Suck Jung
  • Kwang Ha YooEmail author
COPD
  • 143 Downloads

Abstract

Purpose

The economic effect of regular follow-up and early management in patients with early chronic obstructive pulmonary disease (COPD) has not yet been clarified. Therefore, this study aimed to estimate the economic effect of regular follow-up and early management in these patients.

Methods

Patients with early COPD were identified from the Korea National Health and Nutrition Examination Survey. We analyzed medical utilization and cost for 2 years without any missing data by using the Korean National Health Insurance data. Patients with routine healthcare maintenance were defined as, after diagnosis, those with regular visits to the hospital and receiving early management of COPD.

Results

Among 1204 patients with early COPD, the patients who were classified as the group with routine healthcare maintenance (69/146; 47.3%) and the group with intermittent healthcare user (79/1058; 7.5%) visited to hospital for the next 2 years. The patients with routine healthcare maintenance had lower cost of inpatient service and frequencies of emergency room (ER) visit and intensive care unit (ICU) admission than intermittent healthcare users (cost of inpatient service, $4595 vs. $4953 per person; ER visit, 7.2 vs. 11.5; ICU admission, 4.3 vs. 7.7). Even in patients with COPD and FEV1 ≥ 80, early intervention through follow-up reduced the cost of inpatient service because these patients could have had less severe acute exacerbations than intermittent healthcare users.

Conclusion

Patients with early COPD, even those with FEV1 ≥ 80, need regular follow-up for early management and disease control as well as for reducing the socioeconomic burden of the disease.

Keywords

Chronic obstructive pulmonary disease Korea Early intervention Economics 

Abbreviations

COPD

Chronic obstructive pulmonary disease

FEV1

Forced expiratory volume in 1 s

FVC

Forced vital capacity

KNHANES

The Korea National Health and Nutrition Examination Survey

KNHI

The Korean National Health Insurance

PFT

Pulmonary function test

ICD-10

The International Classification of Diseases-Tenth Revision

ER

Emergency room

ICU

Intensive care unit

USD

US dollars

KRW

Korean won

Notes

Acknowledgements

This study was supported by a Grant (No. 2014P3300300) from the Korea Centers for Disease Control and Prevention. This study was supported by COPD cohort data of HIRA.

Author Contributions

LYS, MKH, YKH: Conception and design of the study; LYS, MKH, RCK, JKS, YKH: Data generation (When applicable); LYS, MKH, RCK, KYH, LSY, USJ, LCH, JKS, YKH: Analysis and Interpretation of the data; LYS, MKH, RCK, KYH, LSY, USJ, LCH, JKS, YKH: Preparation or critical revision of the manuscript.

Funding

This study was supported by a grant (2014P3300300) from the Korea Centers for Disease Control and Prevention.

Compliance with Ethical Standards

Conflict of interest

The authors of this study declare that they have no competing interests in regard to this manuscript.

References

  1. 1.
    Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, Yoon HI, Lim SC, Park JY, Park SJ, Seo KH, Kim KU, Oh YM, Lee NY, Kim JS, Oh KW, Kim YT, Park IW, Lee SD, Kim SK, Kim YK, Han SK (2011) Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 16(4):659–665CrossRefGoogle Scholar
  2. 2.
    Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A (2017) Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med 195(5):557–582CrossRefGoogle Scholar
  3. 3.
    Tantucci C, Modina D (2012) Lung function decline in COPD. Int J Chron Obstr Pulm Dis 7:95–99CrossRefGoogle Scholar
  4. 4.
    Lee JY, Rhee CK, Jung KS, Yoo KH (2016) Strategies for management of the early chronic obstructive lung disease. Tuberc Respir Dis 79(3):121–126CrossRefGoogle Scholar
  5. 5.
    Ferguson GT (2011) Maintenance pharmacotherapy of mild and moderate COPD: what is the evidence? Respir Med 105(9):1268–1274CrossRefGoogle Scholar
  6. 6.
    Maltais F, Dennis N, Chan CK (2013) Rationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPD. COPD 10(1):79–103CrossRefGoogle Scholar
  7. 7.
    Elbehairy AF, Webb KA, Neder JA, O’Donnell DE (2013) Should mild COPD be treated? Evidence for early pharmacological intervention. Drugs 73(18):1991–2001CrossRefGoogle Scholar
  8. 8.
    Welte T, Vogelmeier C, Papi A (2015) COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract 69(3):336–349CrossRefGoogle Scholar
  9. 9.
    Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, Nordestgaard BG (2012) Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 186(10):975–981CrossRefGoogle Scholar
  10. 10.
    Leivseth L, Brumpton BM, Nilsen TI, Mai XM, Johnsen R, Langhammer A (2013) GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT study, Norway. Thorax 68(10):914–921CrossRefGoogle Scholar
  11. 11.
    Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138CrossRefGoogle Scholar
  12. 12.
    Jacome C, Marques A (2016) Short- and Long-term effects of pulmonary rehabilitation in patients with mild COPD: a comparison with patients with moderate to severe COPD. J Cardiopulm Rehabil Prev 36(6):445–453CrossRefGoogle Scholar
  13. 13.
    Rhee CK, Kim K, Yoon HK, Kim JA, Kim SH, Lee SH, Park YB, Jung KS, Yoo KH, Hwang YI (2017) Natural course of early COPD. Int J Chron Obstruct Pulm Dis 12:663–668CrossRefGoogle Scholar
  14. 14.
    Ehteshami-Afshar S, FitzGerald JM, Doyle-Waters MM, Sadatsafavi M (2016) The global economic burden of asthma and chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 20(1):11–23CrossRefGoogle Scholar
  15. 15.
    Bustacchini S, Chiatti C, Furneri G, Lattanzio F, Mantovani LG (2011) The economic burden of chronic obstructive pulmonary disease in the elderly: results from a systematic review of the literature. Curr Opin Pulm Med 17(Suppl 1):S35–S41CrossRefGoogle Scholar
  16. 16.
    Kim C, Yoo KH, Rhee CK, Yoon HK, Kim YS, Lee SW, Oh YM, Lee SD, Lee JH, Kim KJ, Kim JH, Park YB (2014) Health care use and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea. Int J Tuberc Lung Dis 18(6):737–743CrossRefGoogle Scholar
  17. 17.
    Srivastava K, Thakur D, Sharma S, Punekar YS (2015) Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics 33(5):467–488CrossRefGoogle Scholar
  18. 18.
    Teo WS, Tan WS, Chong WF, Abisheganaden J, Lew YJ, Lim TK, Heng BH (2012) Economic burden of chronic obstructive pulmonary disease. Respirology 17(1):120–126CrossRefGoogle Scholar
  19. 19.
    Kim J, Rhee CK, Yoo KH, Kim YS, Lee SW, Park YB, Lee JH, Oh Y, Lee SD, Kim Y, Kim K, Yoon H (2013) The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data. Int J Chron Obstruct Pulm Dis 8:561–568Google Scholar
  20. 20.
    Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, Uh ST, Shim JJ, Lew WJ (2005) Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med 172(7):842–847CrossRefGoogle Scholar
  21. 21.
    Hwang JA, Kim YS, Leem AY, Park MS, Kim SK, Chang J, Jung JY (2017) Clinical implications of sarcopenia on decreased bone density in men with chronic obstructive pulmonary disease. Chest 151(5):1018–1027CrossRefGoogle Scholar
  22. 22.
    Hwang YI, Park YB, Yoo KH (2017) Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis 80(3):226–229CrossRefGoogle Scholar
  23. 23.
    Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338CrossRefGoogle Scholar
  24. 24.
    Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, Lee JH, Kim Y, Kim K, Kim J, Oh YM, Lee SD (2014) Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD 11(2):163–170CrossRefGoogle Scholar
  25. 25.
    Bahk J, Kim YY, Kang HY, Lee J, Kim I, Lee J, Yun SC, Park JH, Shin SA, Khang YH (2017) Using the National Health Information Database of the National Health Insurance Service in Korea for monitoring mortality and life expectancy at national and local levels. J Korean Med Sci 32(11):1764–1770CrossRefGoogle Scholar
  26. 26.
    NHIS Available from: https://www.nhis.or.kr/static/html/wbd/g/a/wbdga0101.html. Accessed 22 July 2018
  27. 27.
    Guirguis-Blake JM, Senger CA, Webber EM, Mularski RA, Whitlock EP (2016) Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US Preventive Services Task Force. JAMA 315(13):1378–1393CrossRefGoogle Scholar
  28. 28.
    Jacome C, Marques A (2014) Pulmonary rehabilitation for mild COPD: a systematic review. Respir Care 59(4):588–594CrossRefGoogle Scholar
  29. 29.
    Llor C, Moragas A, Hernandez S, Bayona C, Miravitlles M (2012) Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186(8):716–723CrossRefGoogle Scholar
  30. 30.
    Beeh KM (2016) The role of bronchodilators in preventing exacerbations of chronic obstructive pulmonary disease. Tuberc Respir Dis 79(4):241–247CrossRefGoogle Scholar
  31. 31.
    Dransfield MT, Kunisaki KM, Strand MJ, Anzueto A, Bhatt SP, Bowler RP, Criner GJ, Curtis JL, Hanania NA, Nath H, Putcha N, Roark SE, Wan ES, Washko GR, Wells JM, Wendt CH, Make BJ (2017) Acute Exacerbations and Lung Function Loss in Smokers With and Without COPD. Am J Respir Crit Care Med 195(3):324–330Google Scholar
  32. 32.
    Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931CrossRefGoogle Scholar
  33. 33.
    Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57(10):847–852CrossRefGoogle Scholar
  34. 34.
    Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R (2004) Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 59(5):387–395CrossRefGoogle Scholar
  35. 35.
    Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, Curren K, Balter MS, Bhutani M, Camp PG, Celli BR, Dechman G, Dransfield MT, Fiel SB, Foreman MG, Hanania NA, Ireland BK, Marchetti N, Marciniuk DD, Mularski RA, Ornelas J, Road JD, Stickland MK (2015) Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest 147(4):894–942CrossRefGoogle Scholar
  36. 36.
    Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, Yang IA (2016) Acute exacerbation of COPD. Respirology 21(7):1152–1165CrossRefGoogle Scholar
  37. 37.
    Pavord ID, Jones PW, Burgel PR, Rabe KF (2016) Exacerbations of COPD. Int J Chron Obstruct Pulm Dis 11(Spec Iss):21–30Google Scholar
  38. 38.
    Wedzicha JA, Decramer M, Seemungal TA (2012) The role of bronchodilator treatment in the prevention of exacerbations of COPD. Eur Respir J 40(6):1545–1554CrossRefGoogle Scholar
  39. 39.
    Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JH, Grenier PA, Kauczor HU, Bailey WC, DeMeo DL, Casaburi RH, Friedman P, Van Beek EJ, Hokanson JE, Bowler RP, Beaty TH, Washko GR, Han MK, Kim V, Kim SS, Yagihashi K, Washington L, McEvoy CE, Tanner C, Mannino DM, Make BJ, Silverman EK, Crapo JD (2015) Clinical and radiologic disease in smokers with normal spirometry. JAMA Intern Med 175(9):1539–1549CrossRefGoogle Scholar
  40. 40.
    Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, Gouskova NA, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Lazarus SC, Martinez FJ, Paine R III, Rennard S, Tashkin DP, Han MK (2016) Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 374(19):1811–1821CrossRefGoogle Scholar
  41. 41.
    Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B (2012) Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 7(5):e37483CrossRefGoogle Scholar
  42. 42.
    Tashkin DP (2015) Smoking cessation in chronic obstructive pulmonary disease. Semin Respir Crit Care Med 36(4):491–507CrossRefGoogle Scholar
  43. 43.
    Ford ES, Mannino DM, Wheaton AG, Giles WH, Presley-Cantrell L, Croft JB (2013) Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988–1994 to 2007–2010. Chest 143(5):1395–1406CrossRefGoogle Scholar
  44. 44.
    Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J (2015) Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 373(2):111–122CrossRefGoogle Scholar
  45. 45.
    Mannino DM, Thorn D, Swensen A, Holguin F (2008) Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 32(4):962–969CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Young Seok Lee
    • 1
  • Kyung Hoon Min
    • 1
  • Chin Kook Rhee
    • 2
  • Yong Hyun Kim
    • 3
  • Seong Yong Lim
    • 4
  • Soo-Jung Um
    • 5
  • Chang-Hoon Lee
    • 6
  • Ki-Suck Jung
    • 7
  • Kwang Ha Yoo
    • 8
    Email author
  1. 1.Division of Respiratory and Critical Care Medicine, Department of Internal MedicineKorea University Medical Center, Guro HospitalSeoulRepublic of Korea
  2. 2.Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of MedicineThe Catholic University of KoreaSeoulRepublic of Korea
  3. 3.Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of MedicineThe Catholic University of KoreaSeoulRepublic of Korea
  4. 4.Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kangbuk Samsung HospitalSungkyunkwan University School of MedicineSeoulRepublic of Korea
  5. 5.Division of Respiratory Medicine, Department of Internal MedicineDong-A University College of Medicine, Dong-A University Medical CenterBusanRepublic of Korea
  6. 6.Division of Pulmonary and Critical Care Medicine, Department of Internal MedicineSeoul National University HospitalSeoulRepublic of Korea
  7. 7.Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Sacred Heart HospitalHallym University, Hallym University College of MedicineAnyangRepublic of Korea
  8. 8.Division of Pulmonary and Critical Care Medicine, Department of Internal MedicineKonkuk University School of MedicineSeoulRepublic of Korea

Personalised recommendations